Proteoglycan compositions for treating prostate and bladder inflammatory conditions
OwnerTheoharis C. Theoharidesinventor
Life of this patent
Estimating the term…
Abstract
Compositions with synergistic anti-inflammatory effects in inflammatory diseases resulting from activation and consequent degranulation of mast cells and followed by secretion of inflammatory biomolecules from the activated mast cells, composed of a heavily sulfated, non-bovine proteoglycan such as shark cartilage chondroitin sulfate C, and one or more of a hexosamine sulfate such as D-glucosamine sulfate, a flavone such as quercetin, an unrefined olive kernel extract that increases absorption of these compositions in various routes of administration, S-adenosylmethionine, a histamine-1 receptor antagonist, a histamine-3 receptor agonist, an antagonist of the actions of CRH, caffeine, and a polyamine.
Claims1
A composition for oral use with synergistic anti-inflammatory properties in prostate and bladder conditions induced by the activation of mast cells, consequent degranulation of said cells and subsequent secretion of inflammatory biomelecules, comprising:
- shark cartilage chondroitin sulfate 150 mg;
- Saphona plant quercetin;
- 50 mg;
- shellfish chitin D-glucosamine sulfate, 130 mg;
- rooster crown sodium hyaluronate, 20 mg;
- Saphora plant rutin (quercetin glycoside), 100 mg;
- microfiltered unrefined olive kernel (pit) extract (acidity less than 3% and water less than 5%), 49%;
- suspending agents 40 mg beeswax and 20 mg lecithin;
- in soft gel (from pig gelatin) capsules.
Dependencies are inferred from the claim text.